Industries > Pharma > Direct-to-Patient Market Report 2022-2032

Direct-to-Patient Market Report 2022-2032

Forecasts by Type (Direct-to-Patient Marketing (DTC Prescribed Drug Advertising, Disease Awareness Campaigns, Brand Promotion, Healthcare Services Promotion, Laboratory Testing Promotion, Other), Direct-to-Patient Health Services (Tele Consultation, Drug Prescription, Medical Call Centres, Telesampling, Online Services), Direct-to-Patient Clinical Trials (Tele Health Screening, Investigational Medicinal Product (IMP), Patient Support Systems, Other), Direct-to-Patient Logistics (Prescribed Medicine Delivery, Pre-Clinical Supplies, Clinical Trial Supplies, Home Trial Support, Test Samples Collection, Rest All CSO Services)), by Therapeutics (Cardiovascular Disease, Respiratory Diseases, Oncology, Infectious Diseases, Dermatology, Other), by Model (Depot-to-Patient, Site-to-Patient, Hybrid Model, Direct-From-Patient (DfP), Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

PUBLISHED: 22 November 2022
PAGES: 344
PRODUCT CODE: PHA1194
SUBMARKET: Digital Healthcare

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA1194 Categories: , Tag:

The Direct-to-Patient Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Industry Focus on Patient-Centricity Is Driving the Market Growth
The direct-to-patient and home trial support (DtP/HTS) strategy can provide priceless assistance to patients, regardless of whether they are getting a commercial therapy that has been approved or are taking part in a clinical trial. The DtP strategy has developed over the past ten years, with global adoption expanding dramatically in the last three years, fuelled by an industry focus on patient-centricity that is becoming more intense. This strategy provides considerable benefits for the patient as well as all other parties by enabling patients to obtain individualised care, cutting-edge or well-established therapies without leaving the comfort of their own homes. Technology has changed every part of our everyday life, which makes the world feel smaller than it has ever been.

Businesses in the medical, healthcare, and pharmaceutical industries have refrained from embracing social media for a variety of reasons. Corporations welcomed it, but pharmacists baulked because they thought it would present an excessive amount of legal risk. Even so, a few forerunners in the direct-to-patient sector have prepared the way for others. They have demonstrated that, in the quickly evolving healthcare environment of today, it is not only doable but also crucial. Tens of thousands of branding exercises are sent to patients in the medical field each day.

What Questions Should You Ask before Buying a Market Research Report?
• How is the direct-to-patient (DTP) market evolving?
• What is driving and restraining the direct-to-patient (DTP) market?
• How will each direct-to-patient (DTP) submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each direct-to-patient (DTP) submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading direct-to-patient (DTP) markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the direct-to-patient (DTP) projects for these leading companies?
• How will the industry evolve during the period between 2022 and 2032? What are the implications of direct-to-patient (DTP) projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the direct-to-patient (DTP) market?
• Where is the direct-to-patient (DTP) market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the direct-to-patient (DTP) market today, and over the next 10 years:
• Our 344-page report provides 155 tables and 165 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the direct-to-patient (DTP) market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising direct-to-patient (DTP) prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Type
• Direct-to-Patient Marketing
• Direct-to-Patient Health Services
• Direct-to-Patient Clinical Trials
• Direct-to-Patient Logistics

Direct-to-Patient Marketing
• DTC Prescribed Drug Advertising
• Disease Awareness Campaigns
• Brand Promotion
• Healthcare Services Promotion
• Laboratory Testing Promotion
• Other Direct-to-Patient Marketing

Direct-to-Patient Health Services
• Tele Consultation
• Drug Prescription
• Medical Call Centers
• Telesampling
• Online Services

Direct-to-Patient Clinical Trials
• Tele Health Screening
• Investigational Medicinal Product (IMP)
• Patient Support Systems
• Other Clinical Trial Services

Direct-to-Patient Logistics
• Prescribed Medicine Delivery
• Pre-Clinical Supplies
• Clinical Trial Supplies
• Home Trial Support
• Test Samples Collection
• Rest All CSO Services

Therapeutics
• Cardiovascular Disease
• Respiratory Diseases
• Oncology
• Infectious Diseases
• Dermatology
• Other Therapeutics

Model
• Depot-to-Patient
• Site-to-Patient
• Hybrid Model
• Direct-From-Patient (DfP)
• Other DtP Models

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

MEA
• Turkey
• Saudi Arabia
• South Africa
• UAE
• Rest of MEA

Latin America
• Brazil
• Mexico
• Rest of Latin America

Direct-to-Patient Market Report 2022-2032
Need industry data? Please contact us today.

The report also includes profiles and for some of the leading companies in the Direct-to-Patient Market Report 2022-2032, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Access TeleCare
• Agnity Inc.
• AMD Global Telemedicine
• American Well
• Avel eCare
• Axs Health
• Babylon Health
• Citius Tech
• Dictum Health Inc.
• Doctor Anywhere
• Doctor on Demand
• Health Partners
• Health Tap
• HIMS
• Marken
• 20/20 NOW
• NURX
• Practo Technologies Pvt. Ltd.
• Specialists on call, Inc.
• Teladoc Health Inc.
• True pill
• Up Script Health

Overall world revenue for Direct-to-Patient (DTP) Market, 2022 to 2032 in terms of value the market will surpass US$40,746 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Direct-to-Patient Market Report 2022-2032 report help you?
In summary, our 340+ page report provides you with the following knowledge:

• Revenue forecasts to 2032 for Direct-to-Patient (DTP) Market, 2022 to 2032 Market, with forecasts for type, direct-to-patient marketing, direct-to-patient health services, clinical trials, direct-to-patient logistics, therapeutics, and model, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2032 for five regional and 20 key national markets – See forecasts for the Direct-to-Patient (DTP) Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 22 of the major companies involved in the Direct-to-Patient (DTP) Market, 2022 to 2032.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Direct-to-Patient (DTP) Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Direct-to-Patient Market Report 2022-2032: Forecasts by Type (Direct-to-Patient Marketing (DTC Prescribed Drug Advertising, Disease Awareness Campaigns, Brand Promotion, Healthcare Services Promotion, Laboratory Testing Promotion, Other), Direct-to-Patient Health Services (Tele Consultation, Drug Prescription, Medical Call Centres, Telesampling, Online Services), Direct-to-Patient Clinical Trials (Tele Health Screening, Investigational Medicinal Product (IMP), Patient Support Systems, Other), Direct-to-Patient Logistics (Prescribed Medicine Delivery, Pre-Clinical Supplies, Clinical Trial Supplies, Home Trial Support, Test Samples Collection, Rest All CSO Services)), by Therapeutics (Cardiovascular Disease, Respiratory Diseases, Oncology, Infectious Diseases, Dermatology, Other), by Model (Depot-to-Patient, Site-to-Patient, Hybrid Model, Direct-From-Patient (DfP), Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Direct-to-Patient Market Report 2022-2032


Download sample pages

Complete the form below to download your free sample pages for Direct-to-Patient Market Report 2022-2032


Latest Pharma news

Visiongain Publishes Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2022-2032

The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.

25 November 2022

READ

Visiongain Publishes Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2022

Pharmaceutical Contract Manufacturing Organisations (CMOs) market is projected to grow at a CAGR of 6.9% by 2032.

25 November 2022

READ

Visiongain Publishes Dermatology CROs Market Report 2022-2032

The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.

23 November 2022

READ

Visiongain Publishes Direct-to-Patient Market Report 2022-2032

The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.

22 November 2022

READ